Achieving Consensus on the Treatment of DME with ILUVIEN®
December 4, 2013
The UK body that performs health technology appraisals (NICE) has approved ILUVIEN® for the treatment of chronic DME-associated vision impairment that is considered insufficiently responsive to available therapies. Who, exactly, should receive it?
1 min read